HOME >> BIOLOGY >> NEWS
JCI table of contents, 15 October, 2003

FGF-2 to the rescue following traumatic brain injury

In the October 15 issue of the Journal of Clinical Investigation, Michael Moskowitz and colleagues from Harvard Medical School report that fibroblast growth factor-2 (FGF-2) plays a critical role in the ability of the brain to make new cells following traumatic brain injury (TBI). The authors also demonstrate that administration of FGF-2 boosts the production of new brain cells and protects existing neurons from degeneration following injury. The study suggests that FGF-2 supplementation may improve the outcome of individuals who suffer TBI following motor vehicle accidents or other brain injuries.

The brain can be distinguished from other organs and tissues of the body by its limited ability to repair itself. This lack of self-repair following TBI or disease can often result in severe deficits in cognitive, physical, and psychological skills.

However, in the last several decades, mounting evidence has led to the view of the brain as a dynamic, plastic organ, endowed with some potential for self-repair and regeneration. Recent progress in understanding continued neurogenesis the generation of new neurons (nerve cells) - in the adult brain has raised hopes that self-renewal leading to structural repair by new neurons may even be possible.

Moskowitz and fellow researchers examined the role of FGF-2 in the regulation of neurogenesis and neuron loss in a specific region of the brain known as the hippocampal dentate gyrus (DG), in an animal model of TBI. Mice lacking FGF-2, showed a decreased ability to protect existing neurons and generate new neurons following TBI, when compared to controls, indicating that FGF-2 plays a critical role in stabilizing cell loss following injury.

In an effort to limit cell loss and enhance cell proliferation in the DG following TBI, the authors administered FGF-2 by gene delivery and found that this method was indeed able to limit the
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
15-Oct-2003


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
3. JCI table of contents September 15, 2004
4. JCI table of contents: 1 September, 2004
5. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
6. JCI table of contents, 16 August, 2004
7. JCI table of contents, 2 August, 2004
8. When male fish hum, females swim in, thanks to hormones, adaptable hearing
9. JCI table of contents, 1 July 2004
10. Search and destroy protein turns tables on HIV
11. JCI table of contents, 15 June 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... CITY, Calif. (PRWEB) , ... June 04, 2020 , ... ... for the health and well-being of our attendees, staff, and the public. We ... are unique and safe ways to collaborate virtually,” said Julie Sutcliffe, President of WMIS. ...
(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer and ... Jersey-based Critical Environments Group (CEG) to market and sell its complete line of ... and IT environment infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology ... T cell engagers and TCR-based therapeutics, has implemented Genedata Biologics ® ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... ... This new service offers clients a way to speak with Subject Matter Experts ... arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range of scientific, technical, ... are available normal business hours Monday through Friday from 9:00 am – 5:00 pm ...
(Date:5/14/2020)... (PRWEB) , ... May 13, 2020 , ... ... reporter assays or phenotypic readouts, providing little or no information on the drug’s ... a more comprehensive characterization of compounds by measuring the activity of molecular pathways. ...
(Date:5/1/2020)... ... April 30, 2020 , ... The winners of ... policies, projects, and concepts that are actively engaged and deeply committed to changing ... has taken out the top prize in the Experimental category. , The RASTRUM™ ...
(Date:4/22/2020)... ... 21, 2020 , ... Ripple Science today announced new initiatives ... are working remotely and have paused patient visits, forcing teams to do more ... during this uncertain time by giving research teams free access to Ripple for ...
Breaking Biology Technology:
Cached News: